Starlab Partners with Auxilium to Advance Space Biomanufacturing
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1h ago
0mins
Should l Buy VOYG?
Source: Businesswire
- Biomanufacturing Partnership: Starlab Space LLC has partnered with Auxilium Biotechnologies to provide 3D bioprinting and biofabrication capabilities aboard its commercial space station, significantly advancing research in regenerative medicine and implantable medical devices.
- Innovative Technology Application: Auxilium's AMP-1 3D bioprinter has successfully mass-produced complex structures aboard the International Space Station, and will accelerate the translation from experimental biology to manufacturable products at Starlab, enhancing production capabilities in life sciences.
- Microgravity Advantages: 3D printing in microgravity enables tissue architectures and material properties unattainable under standard gravity, facilitating breakthroughs in drug development, cell growth, and disease modeling, with significant clinical application potential.
- Market-Driven Model: Starlab's business model aims to reduce costs and complexities for researchers and commercial partners, ensuring rapid certification and operation through a single-launch, no-assembly-required design, thereby maximizing research efficiency and outcomes.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VOYG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VOYG
Wall Street analysts forecast VOYG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for VOYG is 38.80 USD with a low forecast of 25.00 USD and a high forecast of 45.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 29.050
Low
25.00
Averages
38.80
High
45.00
Current: 29.050
Low
25.00
Averages
38.80
High
45.00
About VOYG
Voyager Technologies, Inc. is a defense technology and space solutions company. The Company is developing and delivering transformative, mission-critical solutions to customers, enabled by its advanced technology, analytics and space infrastructure capabilities. Its solutions include communications and intelligence collection systems, defense systems, advanced space technology, in-space infrastructure and space mission services. The Company’s business consists of diversified solutions across three business segments: Defense & National Security provides mission-critical solutions to protect dynamic and contested domains; Space Solutions delivers space infrastructure, advanced space technology, science systems and mission services that power commercial, academic and government missions from low-Earth orbit to deep space, and Starlab Space Stations, is a commercial space station planned to succeed the ISS and provide continued permanent human presence in space.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
NASA Awards Voyager $24.5M Contract for ISS Operations Through 2030
- Contract Value and Duration: Voyager Technologies has been awarded a $24.5 million Indefinite Delivery/Indefinite Quantity contract by NASA, spanning four years to provide comprehensive mission management services for the International Space Station, ensuring stability in mission execution for years to come.
- Mission Management Capabilities: The contract encompasses end-to-end services from payload integration to mission operations, safety compliance, and post-mission closeout, showcasing Voyager's ability to manage high-tempo operational requirements and reinforcing its leadership in the space mission management sector.
- Near-Term Mission Plans: Voyager anticipates onboarding three payload missions in the upcoming quarter, reflecting strong demand for ongoing ISS operations and providing the company with a steady pipeline of task orders that ensure sustainable future revenue.
- Historical Performance and Future Outlook: Under a previous NASA contract, Voyager successfully executed over 50 task orders, demonstrating its capability in complex space missions, and will continue to apply the same integrated services for next-generation commercial platforms like Starlab, driving long-term growth for the company.
See More
Starlab Partners with Auxilium to Advance Space Biomanufacturing
- Biomanufacturing Partnership: Starlab Space LLC has partnered with Auxilium Biotechnologies to provide 3D bioprinting and biofabrication capabilities aboard its commercial space station, significantly advancing research in regenerative medicine and implantable medical devices.
- Innovative Technology Application: Auxilium's AMP-1 3D bioprinter has successfully mass-produced complex structures aboard the International Space Station, and will accelerate the translation from experimental biology to manufacturable products at Starlab, enhancing production capabilities in life sciences.
- Microgravity Advantages: 3D printing in microgravity enables tissue architectures and material properties unattainable under standard gravity, facilitating breakthroughs in drug development, cell growth, and disease modeling, with significant clinical application potential.
- Market-Driven Model: Starlab's business model aims to reduce costs and complexities for researchers and commercial partners, ensuring rapid certification and operation through a single-launch, no-assembly-required design, thereby maximizing research efficiency and outcomes.
See More
Auxilium Partners with Starlab to Advance Space Bioprinting
- Space Bioprinting Capabilities: Auxilium will provide 3D bioprinting and biofabrication capabilities aboard the Starlab space station, aimed at enhancing R&D in regenerative medicine, implantable medical devices, and tissue engineering, marking a significant advancement in the field of space biomanufacturing.
- Microgravity Advantage: Auxilium's AMP-1 platform successfully created tiny functional blood vessels aboard the International Space Station in under an hour, an achievement not possible on Earth, which opens possibilities for supporting astronaut health during long missions to the Moon and Mars.
- Accelerating Product Translation: The collaboration with Starlab will accelerate the translation from experimental biology to manufacturable products, positioning AMP-1 as a production facility for the next generation of life science technologies in space, thereby advancing complex tissue engineering applications.
- Innovative Infrastructure: The infrastructure provided by Starlab will lower barriers for industry and academia, fostering high-impact research and manufacturing that will lead to breakthrough therapies, ultimately improving lives on Earth.
See More
Novo Nordisk to Air First Super Bowl Ad Featuring Celebrities
- Advertising Strategy: Novo Nordisk will air its first-ever Super Bowl ad featuring celebrities like DJ Khaled and Kenan Thompson, aiming to leverage this national event to boost brand visibility, despite recent stock price declines due to lowered sales forecasts.
- Increased Market Competition: The company anticipates weaker sales for its weight-loss drugs due to intensified competition, particularly from Eli Lilly and Hims & Hers, which has launched a cheaper version of Wegovy, potentially eroding market share further.
- Space Technology Challenges: Voyager Technologies CEO Dylan Taylor highlighted that building orbiting data centers presents significant challenges in cooling, as heat dissipation must occur through radiation in the absence of a medium, raising the bar for technical design.
- IPO Plans: SpaceX is reportedly eyeing an IPO later this year following its recent merger with xAI, which could provide financial and market expansion support, further solidifying its leadership position in the space industry.
See More
Voyager CEO Discusses Challenges of Space Data Centers
- Timeline for Space Data Centers: Voyager CEO Dylan Taylor stated that a two-year timeframe for developing space data centers is considered 'aggressive', indicating challenges in technology maturation, particularly due to the lack of cooling solutions that could impact project timelines.
- Cooling Technology Challenges: Taylor highlighted that the absence of a medium to conduct heat in space presents a major barrier, as all heat dissipation must occur via radiation, necessitating radiators to be oriented away from the Sun, which complicates the construction of data centers in space.
- Market Investment Interest: Interest in space technology investments has surged over the past year, driven by President Trump's plans to boost defense spending and revamp the national space program, particularly with the anticipated SpaceX IPO later this year fueling investor enthusiasm in the sector.
- Poor Stock Performance: Despite Voyager going public in June, its stock has lost more than half its value since debut, reflecting the investment risks associated with space tech companies, especially in light of Firefly Aerospace's nearly two-thirds drop in value since its August IPO.
See More
Future Prospects of Space Data Centers
- Prospects for Space Data Centers: Voyager Technologies CEO Dylan Taylor stated that space data centers will become a reality, but cooling issues still need to be resolved, with a two-year timeline considered an 'aggressive' target, highlighting the challenges and opportunities in technology development.
- Merger Driving Factors: Tesla CEO Elon Musk emphasized that space data centers are a primary reason for merging SpaceX with xAI, with the deal valued at $1.25 trillion, reflecting the market's high interest in space technology.
- Increased Investment Interest: President Trump's plans to boost defense spending and revamp the national space program have lifted interest in space technology investments over the past year, especially with SpaceX's anticipated IPO later this year attracting more investor attention.
- Confidence in Technology Maturity: Taylor noted that Voyager is collaborating with Palantir, Airbus, and Mitsubishi to launch the Starlab project by 2029, and despite its stock losing over half its value since going public, the company remains confident in the potential of space data processing technology.
See More
NASA Awards Voyager $24.5M Contract for ISS Operations Through 2030
- Contract Value and Duration: Voyager Technologies has been awarded a $24.5 million Indefinite Delivery/Indefinite Quantity contract by NASA, spanning four years to provide comprehensive mission management services for the International Space Station, ensuring stability in mission execution for years to come.
- Mission Management Capabilities: The contract encompasses end-to-end services from payload integration to mission operations, safety compliance, and post-mission closeout, showcasing Voyager's ability to manage high-tempo operational requirements and reinforcing its leadership in the space mission management sector.
- Near-Term Mission Plans: Voyager anticipates onboarding three payload missions in the upcoming quarter, reflecting strong demand for ongoing ISS operations and providing the company with a steady pipeline of task orders that ensure sustainable future revenue.
- Historical Performance and Future Outlook: Under a previous NASA contract, Voyager successfully executed over 50 task orders, demonstrating its capability in complex space missions, and will continue to apply the same integrated services for next-generation commercial platforms like Starlab, driving long-term growth for the company.
See More
Starlab Partners with Auxilium to Advance Space Biomanufacturing
- Biomanufacturing Partnership: Starlab Space LLC has partnered with Auxilium Biotechnologies to provide 3D bioprinting and biofabrication capabilities aboard its commercial space station, significantly advancing research in regenerative medicine and implantable medical devices.
- Innovative Technology Application: Auxilium's AMP-1 3D bioprinter has successfully mass-produced complex structures aboard the International Space Station, and will accelerate the translation from experimental biology to manufacturable products at Starlab, enhancing production capabilities in life sciences.
- Microgravity Advantages: 3D printing in microgravity enables tissue architectures and material properties unattainable under standard gravity, facilitating breakthroughs in drug development, cell growth, and disease modeling, with significant clinical application potential.
- Market-Driven Model: Starlab's business model aims to reduce costs and complexities for researchers and commercial partners, ensuring rapid certification and operation through a single-launch, no-assembly-required design, thereby maximizing research efficiency and outcomes.
See More
Auxilium Partners with Starlab to Advance Space Bioprinting
- Space Bioprinting Capabilities: Auxilium will provide 3D bioprinting and biofabrication capabilities aboard the Starlab space station, aimed at enhancing R&D in regenerative medicine, implantable medical devices, and tissue engineering, marking a significant advancement in the field of space biomanufacturing.
- Microgravity Advantage: Auxilium's AMP-1 platform successfully created tiny functional blood vessels aboard the International Space Station in under an hour, an achievement not possible on Earth, which opens possibilities for supporting astronaut health during long missions to the Moon and Mars.
- Accelerating Product Translation: The collaboration with Starlab will accelerate the translation from experimental biology to manufacturable products, positioning AMP-1 as a production facility for the next generation of life science technologies in space, thereby advancing complex tissue engineering applications.
- Innovative Infrastructure: The infrastructure provided by Starlab will lower barriers for industry and academia, fostering high-impact research and manufacturing that will lead to breakthrough therapies, ultimately improving lives on Earth.
See More
Novo Nordisk to Air First Super Bowl Ad Featuring Celebrities
- Advertising Strategy: Novo Nordisk will air its first-ever Super Bowl ad featuring celebrities like DJ Khaled and Kenan Thompson, aiming to leverage this national event to boost brand visibility, despite recent stock price declines due to lowered sales forecasts.
- Increased Market Competition: The company anticipates weaker sales for its weight-loss drugs due to intensified competition, particularly from Eli Lilly and Hims & Hers, which has launched a cheaper version of Wegovy, potentially eroding market share further.
- Space Technology Challenges: Voyager Technologies CEO Dylan Taylor highlighted that building orbiting data centers presents significant challenges in cooling, as heat dissipation must occur through radiation in the absence of a medium, raising the bar for technical design.
- IPO Plans: SpaceX is reportedly eyeing an IPO later this year following its recent merger with xAI, which could provide financial and market expansion support, further solidifying its leadership position in the space industry.
See More
Voyager CEO Discusses Challenges of Space Data Centers
- Timeline for Space Data Centers: Voyager CEO Dylan Taylor stated that a two-year timeframe for developing space data centers is considered 'aggressive', indicating challenges in technology maturation, particularly due to the lack of cooling solutions that could impact project timelines.
- Cooling Technology Challenges: Taylor highlighted that the absence of a medium to conduct heat in space presents a major barrier, as all heat dissipation must occur via radiation, necessitating radiators to be oriented away from the Sun, which complicates the construction of data centers in space.
- Market Investment Interest: Interest in space technology investments has surged over the past year, driven by President Trump's plans to boost defense spending and revamp the national space program, particularly with the anticipated SpaceX IPO later this year fueling investor enthusiasm in the sector.
- Poor Stock Performance: Despite Voyager going public in June, its stock has lost more than half its value since debut, reflecting the investment risks associated with space tech companies, especially in light of Firefly Aerospace's nearly two-thirds drop in value since its August IPO.
See More
Future Prospects of Space Data Centers
- Prospects for Space Data Centers: Voyager Technologies CEO Dylan Taylor stated that space data centers will become a reality, but cooling issues still need to be resolved, with a two-year timeline considered an 'aggressive' target, highlighting the challenges and opportunities in technology development.
- Merger Driving Factors: Tesla CEO Elon Musk emphasized that space data centers are a primary reason for merging SpaceX with xAI, with the deal valued at $1.25 trillion, reflecting the market's high interest in space technology.
- Increased Investment Interest: President Trump's plans to boost defense spending and revamp the national space program have lifted interest in space technology investments over the past year, especially with SpaceX's anticipated IPO later this year attracting more investor attention.
- Confidence in Technology Maturity: Taylor noted that Voyager is collaborating with Palantir, Airbus, and Mitsubishi to launch the Starlab project by 2029, and despite its stock losing over half its value since going public, the company remains confident in the potential of space data processing technology.
See More
